For some time, it has been appreciated that the InImS in IBD is awry [16–18], centered in CD on nucleotide binding oligomerization domain 2 (nNOD-2), and innate immune responses are enhanced by Toll-like receptor 4 (TLR-4) ligand stimulation. This evidence concerns the gene TLR4 and inflammatory bowel disease.